Alignment Healthcare USA, LLC Pharmacy Quality Alliance award reaffirms Alignment’s commitment to medication adherence and pharmacy excellence for seniors ORANGE, Calif., May 19, 2025 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (NASDAQ: ALHC) has been recognized for excellence in quality for its Medicare Advantage prescription drug (MAPD) plan by the Pharmacy Quality Alliance (PQA). The PQA has measured medication safety for the Centers for Medicare and Medicaid Services (CMS) since 2006, ensuring medication safety, adherence and appropriate use. Out of 633 eligible contracts, only 1.3% achieved recognition, highlighting the significance of this award. “We are incredibly honored to be one of only two MAPD plans recognized by PQA for our unwavering focus on quality and consistency in achieving medication adherence,” said Dawn Maroney, CEO, Alignment Health Plan. “This award reaffirms our mission-driven approach to combine personalized care and commitment to improving outcomes for the seniors we serve to live a healthier lifestyle.” The 2025 PQA Laura Cranston Excellence in Quality Award goes to MAPDs with at least a 4.5-star Part D summary rating and a perfect 5-star rating on all five PQA medication measures used in CMS’s star ratings program. Alignment Health was one of two MAPDs that earned the perfect rating on the following five PQA measures: medication adherence for diabetes medications; medication adherence for hypertension (RAS antagonists); medication adherence for cholesterol (statins); medication therapy management program completion rate for comprehensive medication reviews; and statin use in persons with diabetes. CMS evaluates Medicare plan quality every year based on a 5-star rating system. Alignment’s MAPD plans provide prescription drug coverage with personalized support to help members access the medicine they need to stay healthy, particularly those managing multiple chronic conditions. “We are immensely proud of our team's dedication to advancing pharmacy care,” said Ruby Liu, vice president of pharmacy, Alignment Health. “Medication adherence can be a hurdle for seniors. To address that, Alignment has invested in quality through tested processes, predictive technology and personalized concierge support for our members. This commitment enhances patient health and well-being while also reducing costs for both our members and the organization.” Alignment Health Plan received the PQA Excellence in Quality Award from 2018 to 2022 and the PQA Quality Improvement Award in 2018, becoming the first health plan to receive both PQA awards in the same year. This is the sixth time Alignment has received this honor. Story Continues The PQA has recognized Medicare prescription drug plans for their achievements in medication safety since 2011. Alignment will accept the award at the 2025 PQA Annual Meeting on May 20 in Tampa, Florida. About Alignment Health Alignment Health is championing a new path in senior care that empowers members to age well and live their most vibrant lives. A consumer brand name of Alignment Healthcare (NASDAQ: ALHC), Alignment Health’s mission-focused team makes high-quality, low-cost care a reality for its Medicare Advantage members every day. Based in California, the company partners with nationally recognized and trusted local providers to deliver coordinated care, powered by its customized care model, 24/7 concierge care team and purpose-built technology, AVA®. As it expands its offerings and grows its national footprint, Alignment upholds its core values of leading with a serving heart and putting the senior first. For more information, visit www.alignmenthealth.com. Media Contact Priya Shah mPR, Inc. for Alignment Health [email protected] View Comments
Alignment Health Plan Recognized as One of Two Medicare Advantage Prescription Drug Plans in the U.S. for Excellence in Pharmacy Quality
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research.
Start Your Free Trial Now!Not sure where to invest today?
Kalkine’s latest research highlights three companies identified through in-depth analysis and market insights.
Explore these research reports to learn about companies currently being tracked by our analysts and make more informed investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...